Crews in the News

A pioneer in drug discovery, Craig Crews has developed a game changer in the field of targeted protein degradation. The PROTAC technology has the potential of targeting proteins previously thought undruggable. This brings a new found hope for those battling metastatic prostate cancer. 

For more on this story, visit Nature.com.